tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ARVN Stock Latest News

Arvinas Announces Updates on Clinical Trials Progress
Company AnnouncementsArvinas Announces Updates on Clinical Trials Progress
12d ago
8K
ARVN
Arvinas updates milestones for 2025
PremiumThe Fly
Arvinas updates milestones for 2025
12d ago
ARVN
Arvinas down on investors’ read of Lilly data, says BTIG
PremiumThe Fly
Arvinas down on investors’ read of Lilly data, says BTIG
1M ago
LLY
ARVN
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
1M ago
LLY
ARVN
Arvinas and Pfizer Report Promising Cancer Study Results
PremiumCompany Announcements
Arvinas and Pfizer Report Promising Cancer Study Results
1M ago
8K
ARVN
Arvinas, Pfizer announce initial Phase 1b data from TACTIVE-U sub-study
PremiumThe FlyArvinas, Pfizer announce initial Phase 1b data from TACTIVE-U sub-study
1M ago
PFE
ARVN
Arvinas initiated with a Buy at BTIG
Premium
The Fly
Arvinas initiated with a Buy at BTIG
1M ago
ARVN
Truist biopharma analyst to hold an analyst/industry conference call
Premium
The Fly
Truist biopharma analyst to hold an analyst/industry conference call
2M ago
LLY
PFE
Arvinas price target lowered to $88 from $90 at BMO Capital
PremiumThe Fly
Arvinas price target lowered to $88 from $90 at BMO Capital
2M ago
ARVN
Arvinas initiated with an Overweight at Stephens
PremiumThe Fly
Arvinas initiated with an Overweight at Stephens
2M ago
PFE
ARVN
Arvinas price target lowered to $40 from $50 at Oppenheimer
PremiumThe Fly
Arvinas price target lowered to $40 from $50 at Oppenheimer
3M ago
ARVN
Arvinas Reports Progress in Q3 2024 Financials and Trials
PremiumCompany Announcements
Arvinas Reports Progress in Q3 2024 Financials and Trials
3M ago
ARVN
Arvinas price target lowered to $40 from $50 at Oppenheimer
PremiumThe FlyArvinas price target lowered to $40 from $50 at Oppenheimer
3M ago
ARVN
Arvinas reports Q3 EPS (68c), consensus (96c)
Premium
The Fly
Arvinas reports Q3 EPS (68c), consensus (96c)
3M ago
ARVN
Arvinas participates in a conference call hosted by Truist
Premium
The Fly
Arvinas participates in a conference call hosted by Truist
6M ago
ARVN
Arvinas price target lowered to $48 from $60 at Barclays
PremiumThe Fly
Arvinas price target lowered to $48 from $60 at Barclays
6M ago
ARVN
Arvinas price target lowered to $50 from $70 at Oppenheimer
PremiumThe Fly
Arvinas price target lowered to $50 from $70 at Oppenheimer
6M ago
PFE
ARVN
Arvinas expects cash to fund requirements into 2027
PremiumThe Fly
Arvinas expects cash to fund requirements into 2027
6M ago
ARVN
Arvinas CEO says making ‘meaningful progress’ across portfolio
PremiumThe Fly
Arvinas CEO says making ‘meaningful progress’ across portfolio
6M ago
ARVN
Arvinas reports Q2 EPS (49c), consensus (86c)
PremiumThe FlyArvinas reports Q2 EPS (49c), consensus (86c)
6M ago
ARVN
Milestone Pharmaceuticals appoints Duty, Saik to board of directors
Premium
The Fly
Milestone Pharmaceuticals appoints Duty, Saik to board of directors
6M ago
ARVN
MIST
Arvinas Appoints Andrew Saik as CFO with Equity Incentives
Premium
Company Announcements
Arvinas Appoints Andrew Saik as CFO with Equity Incentives
7M ago
8K
ARVN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >